Product information
From Health Canada
Current status:
Cancelled Pre Market
Current status date:
2018-08-01
Original market date: See footnote 1
Product name:
NEOSTIGMINE METHYLSULFATE INJECTION SDZ
DIN:
02385201 Electronic product monograph is not available
Company:
SANDOZ CANADA INCORPORATED
110 Rue De Lauzon
Boucherville
Quebec
Canada
J4B 1E6
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Subcutaneous , Intravenous , Intramuscular
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
12:04.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
N07AA01 NEOSTIGMINE
Active ingredient group (AIG) number:See footnote5
0102263002
Active ingredient(s) | Strength |
---|---|
NEOSTIGMINE METHYLSULFATE | 0.5 MG / ML |